Use of STAT1 Inhibitors in the Treatment of Brain I/R Injury and Neurodegenerative Diseases

E-ISSN： 1875-6166|11|1|2-7

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.11, Iss.1, 2011-03, pp. : 2-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer

By Buck Elizabeth Mulvihill Mark

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 605-621

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 21, Iss. 24, 2014-08 ,pp. : 2830-2838

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase-1 as a Therapeutic Target in Neurodegenerative Diseases and Brain Infections

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 429-442

Bentham Science Publishers

Access to resources Recommend Favorite

The Future Use of Complement Inhibitors for the Treatment of Neurological Diseases

By McGeer E.G. McGeer P.L.

Drugs, Vol. 55, Iss. 6, 1998-06 ,pp. : 739-746

Adis International

Access to resources Recommend Favorite

Recent progress in the use of glycine transporter-1 inhibitors for the treatment of central and peripheral nervous system diseases

By Slassi Abdelmalik Egle Ian

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 2, 2004-02 ,pp. : 201-214

Informa Healthcare

Access to resources Recommend Favorite